INS and metabolic dysfunction-associated steatotic liver disease: Uric acid may contribute to the accumulation of triglycerides through the enhanced synthesis of fatty acids and lipogenic pathways in the liver, leading to the development of non-alcoholic fatty liver disease (NAFLD), which contributes to the development of chronic hepatitis and resistance to insulin [36].